Kamal Therapeutics, Inc.

Form D Filings

Location
Hingham, MA
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001880064
Previous Names
Kamal Therapeutics, Inc., Phoenicis Therapeutics, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
11/24/2025 Equity $13,807,138 $13,807,138 $17,307,138 $3,500,000 11/10/2025 11/21/2025 D 000188006425000004
10/11/2022 Debt, Option to Acquire $5,626,000 $9,943,000 $10,000,000 $57,000 8/18/2021 10/11/2022 D/A 000188006422000001
8/27/2021 Debt $4,317,000 $4,317,000 $10,000,000 $5,683,000 8/18/2021 8/27/2021 D 000188006421000001